How does CRH's diluted EPS growth of 3% compare with analyst expectations and consensus estimates?
Short answer:
The press‑release you shared does not include any analyst forecasts or consensus estimates for CRH’s diluted earnings‑per‑share (EPS) for Q‑2 2025. Because the article only reports the company‑reported result (diluted EPS $1.94, up 3% year‑over‑year), we cannot directly say whether that 3 % growth beats, meets, or falls short of market expectations.
Why we can’t answer the comparison from the information provided
| What the news tells us | What’s missing for a comparison |
|---|---|
| Reported diluted EPS: $1.94, up 3 % YoY | Analyst consensus EPS for Q2 2025 (or for the full‑year) |
| Other reported metrics (revenues, EBITDA, margins) | Consensus EPS growth rate (e.g., 5 % expected, 2 % expected) |
| Context: “Strong performance backed by demand, pricing and acquisitions” | Analyst rating (outperform, hold, etc.) |
| Date: August 7 2025 (release) | Historical forecast error or confidence intervals |
| Source: Business Wire (company‑issued) | Analyst coverage (number of analysts, source of consensus) |
Since the article is a corporate‑issued press release, it intentionally focuses on the company’s own results and does not contain market expectations. Analyst consensus figures are typically compiled by research firms (e.g., Bloomberg, Refinitiv, FactSet) and are published in separate earnings‑preview articles or in brokerage research notes.
What you would need to make the comparison
Consensus EPS estimate (or EPS growth estimate) for Q2 2025 from a reputable source (e.g., Bloomberg, Refinitiv, FactSet, S&P Global Market Intelligence). This is usually expressed as:
- Absolute EPS (e.g., $1.90) or
- Percent growth versus the prior year (e.g., +4 % YoY)
- Absolute EPS (e.g., $1.90) or
Analyst coverage count (helps assess the robustness of the consensus).
Analyst revisions (if the estimate changed after the release) – sometimes analysts adjust forecasts after a company’s own guidance.
Contextual commentary – whether analysts expected a “beat,” “meet,” or “miss” based on the EPS forecast relative to the company’s guidance.
How to find the missing data
| Source | Typical Access Method |
|---|---|
| Bloomberg Terminal | Run EQS <ticker> <quarter> or check the “Earnings Estimates” tab. |
| Refinitiv (formerly Thomson Reuters) | Use the “Earnings Forecast” function for the ticker (CRH) and select the Q2 2025 period. |
| FactSet | Look under the “Consensus Estimates” tab for the company. |
| S&P Capital IQ | Navigate to “Financials → Estimates” for the period. |
| Brokerage Research | Many broker research notes (e.g., JPMorgan, BofA, Barclays) publish their own EPS forecasts. |
| Financial News Websites (e.g., Yahoo Finance, MarketWatch) | Usually show a consensus EPS and “EPS surprise” metric after results are released. |
How you could phrase the answer once you have the data
“CRH reported diluted earnings per share of $1.94 in Q2 2025, up 3 % year‑over‑year. Analysts, on average, expected EPS of $1.90 (or a 4 % YoY increase) per the Bloomberg consensus of 12 analysts, implying that the actual 3 % growth is slightly below the consensus expectation. Consequently, the EPS result was viewed as a modest miss versus consensus, though the company’s revenue and EBITDA beat expectations, which softened the overall market reaction.”
If the consensus estimate had been $1.97 (or a 5 % growth), the 3 % growth would be a more significant miss; if the consensus had been $1.92 (or a 2 % growth), the 3 % growth would be a *beat*.
Bottom line
- From the news article alone: there is no information about analyst expectations, so we cannot directly compare CRH’s 3 % EPS growth to the market’s consensus.
- To answer the question fully you need to retrieve the consensus EPS estimate (or growth rate) from a financial data provider or brokerage research. Once you have that figure, you can determine whether the 3 % growth represents a beat, a meet, or a miss relative to analyst expectations.